They found that patients with stage IV melanoma with an exosomal protein concentration lower than 50 mgr/mL had longer survival than those with a protein concentration higher than 50 mgr/mL, as well as the expression of TYRP2 increased in individuals who develop metastasis [29]. The gene discussed is DCT; the disease is melanoma.